Drug profile · INN
rivoceranib
rivoceranib is a vascular endothelial growth factor receptor 2 inhibitor.
NMPA: clinical trials
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — rivoceranib
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.70
Quick answer
rivoceranib is a vascular endothelial growth factor receptor 2 inhibitor.
Key facts
INN rivoceranib
Mechanism Vascular endothelial growth factor receptor 2 inhibitor
Mechanism of action
Vascular endothelial growth factor receptor 2 inhibitor
Approval history
| Authority | Status | Date |
|---|---|---|
| NMPA | clinical trials | — |
Frequently asked questions
What is rivoceranib?
rivoceranib is a vascular endothelial growth factor receptor 2 inhibitor.